Evaluate the Relevance of the Use of Peripheral Venous Bl... | NCT05971615 | Trialant

Home
Search
Collections
Views
Audits

Terms of Service
Privacy Policy

Evaluate the Relevance of the Use of Peripheral Venous Bl... | NCT05971615 | Trialant

Studies
Evaluate the Relevance of the Use of Peripheral Venous Blood Gases for the Care of Patients in the S.A.U.V (Vital Emergency Rooms) of the CHU de Caen

NCT05971615

Sponsor

University Hospital, Caen

Status

Completed

Last Update Posted

Aug 2, 2023Actual

Enrollment

90Actual

Phase

Not Applicable

Conditions

Critical Illness

Interventions

peripheral venous blood gases

Countries

France

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

NCT05971615

Obsolete or Duplicate NCT IDs

Not provided

Organization Study

17-076

Secondary IDs

Not provided

Brief Title

Evaluate the Relevance of the Use of Peripheral Venous Blood Gases for the Care of Patients in the S.A.U.V (Vital Emergency Rooms) of the CHU de Caen

Official Title

Evaluate the Relevance of the Use of Peripheral Venous Blood Gases for the Care of Patients in the S.A.U.V (Vital Emergency Rooms) of the CHU de Caen

Acronym

GDS

Organization

University Hospital, CaenOTHER

Status Module

Record Verification Date

Jul 2023

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

No

Start Date

Jan 15, 2020Actual

Primary Completion Date

Dec 18, 2020Actual

Completion Date

Dec 18, 2020Actual

First Submitted Date

May 23, 2023

First Submission Date that Met QC Criteria

Jul 25, 2023

First Posted Date

Aug 2, 2023Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jul 25, 2023

Last Update Posted Date

Aug 2, 2023Actual

Sponsor/Collaborators Module

Responsible Party, by Official Title

Sponsor

Lead Sponsor

University Hospital, CaenOTHER

Collaborators

Not provided

Oversight Module

Has Data Monitoring Committee (DMC)

No

Is FDA Regulated Drug

No

Is FDA Regulated Device

No

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

concordance between the lactate values on peripheral venous and arterial blood gases in all patients receiving an arterial sample on their arrival in the S.A.U.V.

Detailed Description

Not provided

Conditions Module

Conditions

Critical Illness

Keywords

Not provided

Design Module

Study Type

Interventional

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not Applicable

Interventional Study Design

Allocation

Biospecimen

No data available

No data is available for this block.

Enrollment

90Actual

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Peripheral Venous Blood Gases	Other		Other: peripheral venous blood gases

Interventions

Name	Type	Description	Arm Group Labels	Other Names
peripheral venous blood gases	Other	peripheral venous blood gases	Peripheral Venous Blood Gases

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
lactates on peripheral venous and arterial blood gases	mmol/L	baseline

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

one of this condition in emergency unit :
1. acute respiratory distress
2. a suspicion of an acid-base disorder
3. a state of shock
4. Pathologies requiring monitoring of the respiratory system
5. Patient under NIV
6. Poisoning
7. Coma with a Glasgow score < or equal to 8

Exclusion Criteria:

Patient presenting another pathology supported in SAUV not requiring the realization of arterial blood gases
Patient aged < 18 years
Pregnant or breastfeeding woman

Accepts Healthy Volunteers

No

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

70 Years

Standard Ages

AdultOlder Adult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Not provided

Locations

Facility	Status	City	State	ZIP	Country	Contacts
CAEN University Hospital		Caen			France

References Module

No data available

No data is available for this block.

IPD Sharing Statement Module

Plan to Share IPD

No

Description

Not provided

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Jul 10, 2026

Removed Countries

Not provided

Submission Tracking

No data available

No data is available for this block.

Condition Browse Module

MeSH Terms

Intervention Browse Module

No data available

No data is available for this block.

N/A

Intervention Model

Single Group Assignment

Intervention Model Description

Not provided

Primary Purpose

Other

Observational Model

Not provided

Time Perspective

Not provided

Masking Info

Masking

None (Open Label)

Masking Description

Not provided

Who Masked

Not provided

ID	Term
D016638	Critical Illness

Ancestor Terms

ID	Term
D020969	Disease Attributes
D010335	Pathologic Processes
D013568	Pathological Conditions, Signs and Symptoms

Browse Leaves

Not provided

Browse Branches

Not provided